Studies of the H60a locus in C57BL/6 and 129/Sv mouse strains identify the H60a 3'UTR as a regulator of H60a expression

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 539-545

  Zhang, Hui ^a   Hardamon, Chanae ^a   Sagoe, Bright ^a   Ngolab, Jennifer ^a   Bui, Jack D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

H60; Interferon; MicroRNA; Natural killer cells; NKG2D

Indexed keywords

CIS ACTING ELEMENT; GAMMA INTERFERON; MICRORNA; MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN 60; UNCLASSIFIED DRUG;

129 SV MOUSE; 3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE LOCUS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SARCOMA; STRAIN DIFFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE; CHROMOSOMES, MAMMALIAN; DEAD-BOX RNA HELICASES; ENDORIBONUCLEASES; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC LOCI; GENOME; INTERFERON-GAMMA; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SEQUENCE ALIGNMENT;

MUS;

EID: 78650614879     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.10.015     Document Type: Article

References (30)

1. Andresen L., Jensen H., Pedersen M.T., Hansen K.A., Skov S. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J. Immunol. 2007, 179:8235-8242.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Buchau A.S., Morizane S., Trowbridge J., Schauber J., Kotol P., Bui J.D., Gallo R.L. The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J. Immunol. 2010, 184:369-378.
4. Bui J.D., Carayannopoulos L.N., Lanier L.L., Yokoyama W.M., Schreiber R.D. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J. Immunol. 2006, 176:905-913.
5. Bui J.D., Uppaluri R., Hsieh C.S., Schreiber R.D. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 2006, 66:7301-7309.
6. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000, 12:721-727.
7. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001, 1:41-49.
8. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 2000, 1:119-126.
9. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001, 413:165-171.
10. Gasser S., Orsulic S., Brown E.J., Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190.
11. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001, 294:605-609.
12. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6879-6884.
13. Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002, 419:734-738.
14. Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., Knoblaugh S., Cado D., Greenberg N.R., Raulet D.H. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008, 28:571-580.
15. Kato N., Tanaka J., Sugita J., Toubai T., Miura Y., Ibata M., Syono Y., Ota S., Kondo T., Asaka M., Imamura M. Regulation of the expression of MHC class I-related chain A, B (MICA,MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 2007, 21:2103-2108.
16. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 2003, 197:1245-1253.
17. Malarkannan S., Shih P.P., Eden P.A., Horng T., Zuberi A.R., Christianson G., Roopenian D., Shastri N. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 1998, 161:3501-3509.
18. Mistry A.R., O'Callaghan C.A. Regulation of ligands for the activating receptor NKG2D. Immunology 2007, 121:439-447.
19. Nausch N., Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008, 27:5944-5958.
20. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
21. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003, 3:781-790.
22. Samarakoon A., Chu H., Malarkannan S. Murine NKG2D ligands: "double, double toil and trouble" Mol. Immunol. 2009, 46:1011-1019.
23. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., Schreiber R.D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111.
24. Smyth M.J., Swann J., Cretney E., Zerafa N., Yokoyama W.M., Hayakawa Y. NKG2D function protects the host from tumor initiation. J. Exp. Med. 2005, 202:583-588.
25. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 2008, 9:1065-1073.
26. Takada A., Yoshida S., Kajikawa M., Miyatake Y., Tomaru U., Sakai M., Chiba H., Maenaka K., Kohda D., Fugo K., Kasahara M. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J. Immunol. 2008, 180:1678-1685.
27. Uppaluri R., Sheehan K.C., Wang L., Bui J.D., Brotman J.J., Lu B., Gerard C., Hancock W.W., Schreiber R.D. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 2008, 86:137-147.
28. Whang M.I., Guerra N., Raulet D.H. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin. J. Immunol. 2009, 182:4557-4564.
29. Yadav D., Ngolab J., Lim R.S., Krishnamurthy S., Bui J.D. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J. Immunol. 2009, 182:39-43.
30. Yokoyama W.M. Now you see it, now you don't!. Nat. Immunol. 2000, 1:95-97.